Total Revenue
ResMed Total Revenue increased by 0.6% to $1.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $1.29B to $1.43B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 12.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $876.10M | $904.02M | $894.87M | $864.50M | $914.74M | $950.29M | $1.03B | $1.12B | $1.12B | $1.10B | $1.16B | $1.20B | $1.22B | $1.22B | $1.28B | $1.29B | $1.35B | $1.34B | $1.42B | $1.43B |
| QoQ Change | — | +3.2% | -1.0% | -3.4% | +5.8% | +3.9% | +8.8% | +8.0% | +0.5% | -1.8% | +5.5% | +2.9% | +2.2% | +0.1% | +4.7% | +0.8% | +4.4% | -0.9% | +6.5% | +0.6% |
| YoY Change | — | — | — | — | +4.4% | +5.1% | +15.5% | +29.2% | +22.7% | +16.0% | +12.5% | +7.2% | +9.0% | +11.1% | +10.3% | +7.9% | +10.2% | +9.1% | +11.0% | +10.8% |
Product Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Devices | — | $1.25B | $1.34B | $1.35B | — | $1.36B | $1.45B | $1.47B |
| Sleep And Breathing Health | — | $1.07B | $1.13B | $1.13B | $1.18B | $1.17B | $1.26B | $1.26B |
| Masks and other | — | $883.90M | $912.58M | $908.74M | — | $978.27M | $1.06B | $1.05B |
| Residential Care Software | — | $156.77M | $156.50M | $161.16M | $167.01M | $166.14M | $166.87M | $170.89M |
| Sleep and Respiratory Care | $1.07B | — | — | — | — | — | — | — |
| Software as a Service | $146.03M | — | — | — | — | — | — | — |
| Total | $1.22B | $1.22B | $1.28B | $1.29B | $1.35B | $1.34B | $1.42B | $1.43B |
Software as a Service is derived from annual filings.
Sleep and Respiratory Care, Software as a Service were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Total Sleep and Respiratory Care
| Segment | Q2 '21 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|
| Total Sleep and Respiratory Care | $780.33M | $963.04M | $1.02B | $1.05B | $1.07B |
| Software As Service | $95.78M | — | — | — | — |
| Total | $876.10M | $1.10B | $1.16B | $1.20B | $1.22B |
Software As Service, Total Sleep and Respiratory Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Sleep and Breathing Health
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Sleep and Breathing Health | $1.07B | $1.13B | $1.13B | $1.18B | $1.17B | $1.26B | $1.26B |
| Residential Care Software | $156.77M | $156.50M | $161.16M | $167.01M | $166.14M | $166.87M | $170.89M |
| Total | $1.22B | $1.28B | $1.29B | $1.35B | $1.34B | $1.42B | $1.43B |
Geographic Breakdown — Global revenue
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Global revenue | $1.20B | $1.22B | $1.22B | $1.28B | $1.29B | $1.34B | $1.42B | $1.43B |
| U.S., Canada and Latin America | $687.47M | — | $707.31M | $748.95M | $749.32M | $774.75M | $835.03M | $818.67M |
| Combined Europe, Asia and other markets | $361.55M | $343.86M | $360.43M | $376.64M | $381.26M | $394.69M | $420.91M | $441.84M |
| Total | $1.20B | $1.22B | $1.22B | $1.28B | $1.29B | $1.34B | $1.42B | $1.43B |
Geographic Breakdown — Rest of the World
Total Revenue at Other Companies
Frequently Asked Questions
- What is ResMed's total revenue?
- ResMed (RMD) reported total revenue of $1.43B in Q1 2026.
- How has ResMed's total revenue changed year-over-year?
- ResMed's total revenue increased by 10.8% year-over-year, from $1.29B to $1.43B.
- What is the long-term trend for ResMed's total revenue?
- Over 4 years (2021 to 2025), ResMed's total revenue has grown at a 12.6% compound annual growth rate (CAGR), from $3.20B to $5.15B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.